CD20 has no prognostic significance in children with precursor B-cell acute lymphoblastic leukemia.
作者信息
Naithani Rahul, Asim Muhammad, Abdelhaleem Mohammad, Punnett Angela
机构信息
Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Canada.
出版信息
Haematologica. 2012 Sep;97(9):e31-2. doi: 10.3324/haematol.2012.068288.
Abstract
摘要
相似文献
1
CD20 has no prognostic significance in children with precursor B-cell acute lymphoblastic leukemia.CD20在儿童前体B细胞急性淋巴细胞白血病中无预后意义。
Haematologica. 2012 Sep;97(9):e31-2. doi: 10.3324/haematol.2012.068288.
2
CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value.B细胞前体急性淋巴细胞白血病中CD20表达在墨西哥患者中很常见且缺乏预后价值。
Hematology. 2012 Mar;17(2):66-70. doi: 10.1179/102453312X13221316477741.
3
Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia.CD20表达在儿童B细胞前体急性淋巴细胞白血病中的预后意义
Blood. 2006 Nov 15;108(10):3302-4. doi: 10.1182/blood-2006-04-016709. Epub 2006 Aug 8.
4
The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia.CD73在B细胞急性淋巴细胞白血病中通过流式细胞术进行微小残留病监测的应用。
Leuk Lymphoma. 2016 May;57(5):1174-81. doi: 10.3109/10428194.2015.1070153. Epub 2015 Oct 5.
5
Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.通过比较表型图谱检测儿童B细胞前体急性淋巴细胞白血病中的残留疾病：方法及意义
Leuk Lymphoma. 2000 Jul;38(3-4):295-308. doi: 10.3109/10428190009087020.
6
Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.儿童急性淋巴细胞白血病微小残留病检测中原始细胞的免疫表型调节
Folia Med (Plovdiv). 2016 Mar 1;58(1):28-35. doi: 10.1515/folmed-2016-0004.
7
CD20 and Outcome of Childhood Precursor B-cell Acute Lymphoblastic Leukemia: A Meta-analysis.CD20与儿童前体B细胞急性淋巴细胞白血病的预后：一项荟萃分析。
J Pediatr Hematol Oncol. 2015 Apr;37(3):e138-42. doi: 10.1097/MPH.0000000000000256.
8
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.儿童B细胞前体急性淋巴细胞白血病诱导治疗期间CD20上调：为抗CD20定向免疫治疗奠定基础。
Blood. 2008 Nov 15;112(10):3982-8. doi: 10.1182/blood-2008-06-164129. Epub 2008 Sep 9.
9
No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia.B系急性淋巴细胞白血病患儿缓解诱导治疗结束时免疫表型变化无预后意义。
Leuk Res. 2018 May;68:57-61. doi: 10.1016/j.leukres.2018.03.001. Epub 2018 Mar 2.
10
Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.CD81 和 CD58 在小儿 B 淋巴细胞白血病微小残留病检测中的作用。
Int J Lab Hematol. 2018 Jun;40(3):343-351. doi: 10.1111/ijlh.12795. Epub 2018 Mar 2.
引用本文的文献
1
The different predictive effects of the intensity and proportion of CD20 expression on the prognosis of B-lineage acute lymphocyte leukemia.CD20表达强度及比例对B系急性淋巴细胞白血病预后的不同预测作用。
EJHaem. 2022 Mar 25;3(2):443-452. doi: 10.1002/jha2.414. eCollection 2022 May.
本文引用的文献
1
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease.CD20 表达在费城染色体阴性 B 前体细胞急性淋巴细胞白血病中无预后作用：微小残留病分子研究的新见解。
Haematologica. 2012 Apr;97(4):568-71. doi: 10.3324/haematol.2011.054064. Epub 2011 Nov 4.
2
Progress of minimal residual disease studies in childhood acute leukemia.儿童急性白血病微小残留病研究进展。
Curr Hematol Malig Rep. 2010 Jul;5(3):169-76. doi: 10.1007/s11899-010-0056-8.
3
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.儿童急性淋巴细胞白血病微小残留病的临床意义及其与其他预后因素的关系：一项儿童肿瘤研究组的研究
Blood. 2008 Jun 15;111(12):5477-85. doi: 10.1182/blood-2008-01-132837. Epub 2008 Apr 3.
4
Acute lymphoblastic leukaemia.急性淋巴细胞白血病
Lancet. 2008 Mar 22;371(9617):1030-43. doi: 10.1016/S0140-6736(08)60457-2.
Zotero 插件